Rankings
▼
Calendar
SRPT Q1 2021 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$147M
+29.3% YoY
Gross Profit
$125M
84.8% margin
Operating Income
-$152M
-103.4% margin
Net Income
-$167M
-113.8% margin
EPS (Diluted)
$-2.10
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
-$180M
Free Cash Flow
-$202M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$2.8B
Total Liabilities
$2.2B
Stockholders' Equity
$535M
Cash & Equivalents
$1.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$147M
$114M
+29.3%
Gross Profit
$125M
$101M
+23.3%
Operating Income
-$152M
-$118M
-28.7%
Net Income
-$167M
-$17M
-856.2%
Revenue Segments
E X O N D Y S Fifty One
$107M
86%
V Y O N D Y S Fifty Three
$18M
14%
A M O N D Y S Fourty Five
$193,000
0%
← FY 2021
All Quarters
Q2 2021 →